These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 24507527

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
    Ozakbas S, Cagiran I, Ormeci B, Idiman E.
    J Neurol Sci; 2004 Mar 15; 218(1-2):3-7. PubMed ID: 14759626
    [Abstract] [Full Text] [Related]

  • 5. Comparison of patient-reported outcome measures in multiple sclerosis.
    Schäffler N, Schönberg P, Stephan J, Stellmann JP, Gold SM, Heesen C.
    Acta Neurol Scand; 2013 Aug 15; 128(2):114-21. PubMed ID: 23398571
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH, Vincent AS.
    Disabil Rehabil; 2013 Aug 15; 35(22):1877-84. PubMed ID: 23600712
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Composite end points to assess delay of disability progression by MS treatments.
    Zhang J, Waubant E, Cutter G, Wolinsky J, Leppert D.
    Mult Scler; 2014 Oct 15; 20(11):1494-501. PubMed ID: 24675040
    [Abstract] [Full Text] [Related]

  • 10. Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
    Karabudak R, Dahdaleh M, Aljumah M, Alroughani R, Alsharoqi IA, AlTahan AM, Bohlega SA, Daif A, Deleu D, Amous A, Inshasi JS, Rieckmann P, Sahraian MA, Yamout BI.
    Mult Scler Relat Disord; 2015 May 15; 4(3):192-201. PubMed ID: 26008936
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical outcome measures for research in multiple sclerosis.
    Balcer LJ.
    J Neuroophthalmol; 2001 Dec 15; 21(4):296-301. PubMed ID: 11756863
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis.
    Sharrack B, Hughes RA.
    Mult Scler; 1999 Aug 15; 5(4):223-33. PubMed ID: 10467380
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
    Ontaneda D, LaRocca N, Coetzee T, Rudick R, NMSS MSFC Task Force.
    Mult Scler; 2012 Aug 15; 18(8):1074-80. PubMed ID: 22740488
    [Abstract] [Full Text] [Related]

  • 18. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].
    Pascual AM, Boscá I, Escutia M, Bernat A, Coret F, Casanova B.
    Neurologia; 2008 Mar 15; 23(2):73-7. PubMed ID: 17641984
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcome measures in multiple sclerosis.
    Amato MP, Portaccio E.
    J Neurol Sci; 2007 Aug 15; 259(1-2):118-22. PubMed ID: 17376487
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.